YTE reported $178.22M in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
Agenus AGEN:US USD -56715000 7.48M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Biogen BIIB:US USD 821M 53.8M
Bluebird Bio BLUE:US USD -76513000 16.99M
Clovis Oncology CLVS:US USD -55979000 15.39M
Cti Biopharma CTIC:US USD -15705000 6.95M
Exelixis EXEL:US USD 92.04M 3.53M
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
IONIS PHARMACEUT IONS:US USD -47000000 56M
Macrogenics MGNX:US USD -24813000 16.49M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Newlink Genetics NLNK:US USD -7251000 593K
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
YTE INCY:US USD 178.22M 131.36M